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Abstract
Tissue macrophages are derived exclusively from blood monocytes, which as monocyte-derived macrophages support HIV-
1 replication. However, among human tissue macrophages only intestinal macrophages are non-permissive to HIV-1,
suggesting that the unique microenvironment in human intestinal mucosa renders lamina propria macrophages non-
permissive to HIV-1. We investigated this hypothesis using blood monocytes and intestinal extracellular matrix (stroma)-
conditioned media (S-CM) to model the exposure of newly recruited monocytes and resident macrophages to lamina
propria stroma, where the cells take up residence in the intestinal mucosa. Exposure of monocytes to S-CM blocked up-
regulation of CD4 and CCR5 expression during monocyte differentiation into macrophages and inhibited productive HIV-1
infection in differentiated macrophages. Importantly, exposure of monocyte-derived macrophages simultaneously to S-CM
and HIV-1 also inhibited viral replication, and sorted CD4
+ intestinal macrophages, a proportion of which expressed CCR5
+,
did not support HIV-1 replication, indicating that the non-permissiveness to HIV-1 was not due to reduced receptor
expression alone. Consistent with this conclusion, S-CM also potently inhibited replication of HIV-1 pseudotyped with
vesicular stomatitis virus glycoprotein, which provides CD4/CCR5-independent entry. Neutralization of TGF-b in S-CM and
recombinant TGF-b studies showed that stromal TGF-b inhibited macrophage nuclear translocation of NF-kB and HIV-1
replication. Thus, the profound inability of intestinal macrophages to support productive HIV-1 infection is likely the
consequence of microenvironmental down-regulation of macrophage HIV-1 receptor/coreceptor expression and NF-kB
activation.
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Introduction
Macrophages play crucial roles in the establishment, pathogen-
esis and latency of human immunodeficiency virus-1 (HIV-1)
infection [1,2,3] through their ability to support viral replication
[4,5], transmit virus [6] and act as a viral reservoir [6,7,8,9]. In
this connection, macrophages throughout the body, including
lymphoid tissue macrophages [10,11], brain microglia [12] and
genital (vaginal) macrophages [13], are permissive to HIV-1. In
sharp contrast, resident macrophages in the human small intestine
are profoundly incapable of supporting productive HIV-1
infection [13,14,15], although intestinal macrophages are derived
exclusively from blood monocytes [16], which when differentiated
into monocyte-derived macrophages are HIV-1 permissive
[4,5,17,18]. The unique non-permissiveness of intestinal macro-
phages to HIV-1 stands in marked contrast to the ability of
intestinal CD4
+ T cells to support productive viral infection and
undergo early, rapid and profound depletion during primary HIV-
1 and SIV infection [19,20,21,22,23,24,25,26].
After their recruitment into the lamina propria, pro-inflamma-
tory blood monocytes differentiate into non-inflammatory intesti-
nal macrophages through stromal transforming growth factor b
(TGF-b)-mediated Smad-induced IkBa and nuclear factor kappa
B (NF-kB) inactivation, as we recently reported [27,28]. In further
contrast to blood monocytes, intestinal macrophages are markedly
down-regulated for receptors that mediate inflammatory respons-
es, including LPS, Fcc and Fca receptors [27,28,29], triggering
receptor expressed on myeloid cells-1 (TREM-1) [30,31], as well
as CD4, CCR5 and CXCR4 [13,14,15]. Since CCR5 expression
correlates directly with the differentiation of monocytes into
macrophages [32,33,34], the reduced expression of CCR5 on
intestinal macrophages raises the possibility that the non-
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reduced HIV-1 receptor/co-receptor expression. However, our
detection of proviral DNA in isolated intestinal macrophages
exposed to HIV-1 in vitro [14] suggests post-entry restriction also
may be involved in the inability of intestinal macrophages to
support HIV-1 replication.
To elucidate the mechanism that renders intestinal macrophages
non-permissive to HIV-1, we exposed blood monocytes and
monocyte-derived macrophages to conditioned media from cultured
l a m i n ap r o p r i as t r o m ai s o l a t e df r o mn o r m a lh u m a nj e j u n u mt o
determine the effect of the lamina propria microenvironment on CD4/
CCR5 expression and HIV-1 permissiveness. Our results indicate that
the inability of primary human intestinal macrophages to support
HIV-1 replication is likely due not only to the marked down-regulation
of CD4 and CCR5 but also to the inability of intestinal macrophages to
activate NF-kB, a critical requirement for HIV-1 transcription.
Results
Intestinal macrophages express markedly reduced levels
of CD4, CCR5 and CXCR4
CCR5-tropic HIV-1 strains are predominant among the
transmitted/founder viruses isolated from acutely infected persons
[35,36,37]. Since the gastrointestinal mucosa is the largest
reservoir of macrophages in the body [38], and macrophages
are an important HIV-1 target cell, we initiated studies to define
the HIV-1 receptor phenotype and permissiveness of purified
intestinal macrophages to macrophage-tropic HIV-1. Intestinal
macrophages and blood monocytes were isolated from the same
donors, purified and analyzed for expression of the HIV-1 primary
receptor CD4 and the coreceptors CCR5 and CXCR4. As shown
in Table 1, very low proportions of intestinal macrophages
expressed CD4 (1.0%), CCR5 (0.8%) and CXCR4 (2.1%), and a
barely detectable proportion (0.3%) expressed both CD4 and
CCR5 (P=0.0001 to P=0.039), consistent with our earlier finding
of markedly diminished CD4, CCR5 and CXCR4 expression on
intestinal but not vaginal macrophages [13]. The low levels of
CD4 and CCR5 expressed on intestinal macrophages correspond-
ed to low levels of receptor/co-receptor-specific mRNA [13]. In
contrast, modest proportions of blood monocytes expressed CD4
(11.6%), CCR5 (2.9%) and CXCR4 (14.1%), and 2.2% of the
monocytes were CD4
+CCR5
+, indicating that 3- to 10-fold fewer
intestinal macrophages expressed the receptors compared to
autologous blood monocytes (Table 1).
CD4
+ intestinal macrophages do not support HIV-1
replication
We previously showed that isolated intestinal macrophages do
not support HIV-1 replication [13,14,15]. The low level of CD4,
as well as CCR5, on intestinal macrophages (Table 1) raised the
possibility that a restriction in HIV-1 entry could contribute to the
cells’ non-permissiveness to HIV-1. To address this possibility, we
sorted autologous CD4
+ intestinal macrophages and blood
monocytes by magnetic activated cell sorting (MACS), cultured
the cells for 4 days (.98% viable), inoculated each population with
equivalent amounts of highly fusigenic and macrophage-tropic R5
viruses, including NA420 B33, NA20 B59 or NA353 B27, which
infect cells with extremely low levels of CD4 and/or CCR5
expression [39], and monitored viral replication by p24 release
over 20 days. As shown in Figure 1, 95% of both the intestinal
macrophages and blood monocytes were HLA-DR
+CD13
+.
Among the sorted CD4
+ intestinal macrophages, 34.1% expressed
CCR5 and levels of p24 were barely detectable only on day 12,
whereas among the sorted CD4
+ blood monocytes, 26% expressed
CCR5 and large amounts of p24 were released by the monocyte-
derived macrophages up to day 20 (Figure 1). Importantly,
neither the exposure of intestinal macrophages to pro-inflamma-
tory stimuli, including lipopolysacharride, interferon-c or tumor
necrosis factor-a, nor culture for up to 2 weeks prior to inoculation
with virus, induced HIV-1 permissiveness in the macrophages
(data not shown). These findings indicate that even CD4
+
intestinal macrophages that express CCR5 are refractory to
HIV-1, implicating a post-entry mechanism for down-regulated
HIV-1 permissiveness. However, the profound low level of CD4
and CCR5 expression on the total intestinal macrophage
population (Table 1) raised the possibility that the mucosal
microenvironment of the jejunum caused the down-regulation of
CD4 and CCR5, thereby also contributing to the reduced
permissiveness of intestinal macrophages to CCR5-tropic HIV-1.
Intestinal stroma-conditioned media (S-CM) blocks
macrophage CD4 and CCR5 expression and HIV-1
replication
Intestinal macrophages are terminally differentiated and express
very low levels of CD4 and CCR5, but they are derived from
Table 1. HIV-1 receptor and co-receptor expression on
purified intestinal macrophages and autologous blood
monocytes.
Intestinal
Macrophages Monocytes P value
c
Mean
a ±SEM
b Mean ±SEM
CD4
+ 1.0 0.3 11.6 2.0 0.0001
CCR5
+ 0.8 0.3 2.9 1.0 0.039
CXCR4
+ 2.1 0.7 14.1 4.4 0.008
CD4
+CCR5
+ 0.3 0.1 2.2 0.6 0.001
CD4
+CXCR4
+ 0.4 0.2 4.4 0.9 0.0002
aMean percentage of positive cells (5 donors);
bSEM, standard error of mean;
cP value is calculated by Student t-test.
doi:10.1371/journal.ppat.1002060.t001
Author Summary
Human intestinal macrophages, unlike lymphoid tissue
macrophages, brain microglia and genital (vaginal) mac-
rophages, are profoundly incapable of supporting produc-
tive HIV-1 infection. Intriguingly, all macrophages are
derived exclusively from blood monocytes, which are HIV-
1 permissive after differentiation into monocyte-derived
macrophages. Therefore, the unique non-permissiveness
of intestinal macrophages to HIV-1 must be conferred by
the intestinal mucosal microenvironment. Here we report
that intestinal stroma potently blocked up-regulation of
HIV-1 receptor/coreceptor CD4 and CCR5 expression
during monocyte differentiation into macrophages and
macrophage nuclear translocation of NF-kB, which is a
critical requirement for HIV-1 transcription. These two
mechanisms work collaboratively to render intestinal
macrophages non-permissive to HIV-1. Harnessing this
natural antiviral defense may provide a novel strategy to
exploit for the prevention of infection in HIV-1 permissive
cells.
HIV-1 Non-Permissiveness in Intestinal Macrophages
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adherent macrophages, express high levels of CD4 and CCR5.
Since factors released by the intestinal extracellular matrix
(stroma) down-regulate an array of innate response receptors on
blood monocytes [27], we examined whether stromal factors
present in conditioned media derived from normal intestinal
stroma (S-CM) [27,28] also down-regulate CD4 and CCR5
expression on blood monocytes during and after their differenti-
ation into macrophages. Compared to monocytes differentiated
into adherent macrophages during 2 days culture in media alone,
monocytes differentiated into macrophages in the presence of S-
CM (10–500 mg protein/mL) displayed a marked dose-dependent
decrease in surface CD4 and CCR5 (Figure 2A). In contrast,
when monocytes were first differentiated for 4 days into adherent
macrophages and then exposed for 2 days to S-CM, CD4 and
CCR5 expression was not down-regulated (Figure 2B). Thus,
intestinal stromal products prevent differentiation-induced upre-
gulation of CD4 and CCR5 expression on monocyte-derived
macrophages but do not down-regulate receptor/co-receptor
expression after the cells have differentiated into macrophages.
These findings offer an explanation for the near absence of CD4
and CCR5 on terminally differentiated intestinal macrophages,
which are derived exclusively from circulating monocytes that
have recruited into the lamina propria.
Since undifferentiated monocytes do not support productive
HIV-1 infection, we next determined whether monocyte-derived
macrophages exposed to lamina propria stromal products
supported HIV-1 replication. Monocyte-derived macrophages
Figure 1. CD4
+ intestinal macrophages do not support HIV-1 replication. CD4
+ intestinal macrophages and blood monocytes were purified
from jejunal and blood MNLs from the same donor by MACS sorting, cultured for 4 days, inoculated with highly macrophage-tropic R5 viruses
(MOI=1) and monitored for p24 production at 4-day intervals for 20 days (n=2 donors, p24 determinations for each donor in triplicate). Inset dot
plots show staining with isotype control antibodies. The % in the histograms indicates percentage of CCR5
+ cells among CD13
+CD4
+ cells.
doi:10.1371/journal.ppat.1002060.g001
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of S-CM, after which the cultures were inoculated with R5 virus
(NA353 B27). As shown in Figure 3A, the pre-incubation of
monocyte-derived macrophages with S-CM prior to the inocula-
tion of HIV-1 caused a dose-dependent decrease in p24
production during a 20-day culture period. However, when
monocyte-derived macrophages were pre-incubated with condi-
tioned media from purified cultures of intestinal epithelial cells
(EC-CM) [40] or intestinal mononuclear cells (MNL-CM) [27]
derived from the same donor tissue as the S-CM, HIV-1
replication was not inhibited (Figure 3B). Furthermore, S-CM
also caused a dose-dependent decrease in viral replication when S-
CM and virus were added simultaneously to the monocyte-derived
macrophage cultures (Figure 3C). These findings suggest that
extracellular matrix products, rather than intestinal epithelial cell
or lamina propria mononuclear cell products, inhibit productive
HIV-1 infection in intestinal macrophages and that the down-
regulation in viral replication is not the exclusive consequence of
the low level of CD4 and CCR5 expression on the macrophages.
S-CM blocks macrophage permissiveness to vesicular
stomatitis virus glycoprotein (VSV-G) pseudotyped virus
To further distinguish between reduced HIV-1 entry and down-
regulated viral replication, we pseudotyped HIV-1 with VSV-G
envelope to bypass HIV-1 receptor/co-receptor-dependent entry.
As predicted, treatment of monocyte-derived macrophages with S-
CM for up to 24 hours did not impair the entry of VSV-G
pseudotyped virus into the cells (data not shown) but caused a
dose-dependent reduction in single-round replication of VSV-G
pseudovirons, as shown by immunofluorescence and flow
cytometry in Figure 4, upper panels. The same pre-treatment
of monocyte-derived macrophages with S-CM also inhibited
infection of YU2 pseudovirons in a dose-dependent manner
(Figure 4, lower panels). These results further indicate that S-
CM inhibition of R5 replication was not due only to down-
regulated CD4 and CCR5 expression but also involved post-entry
restriction in viral replication.
Stromal TGF-b inhibits NF-kB activation and down-
regulates HIV-1 replication in monocyte-derived
macrophages
We have shown that stromal TGF-b inactivates NF-kBi n
monocyte-derived macrophages by dysregulating NF-kB signal
proteins and inducing IkBa, the cytoplasmic negative regulator of
NF-kB [28]. Because NF-kB is required for HIV-1 transcription
[41], we investigated whether stromal TGF-b-mediated down-
regulation of NF-kB also inhibits the ability of monocyte-derived
macrophages to support HIV-1 replication. Monocyte-derived
macrophages were cultured in triplicate with increasing concen-
trations of S-CM and inoculated with R5 HIV-1 (NA353 B27) at a
multiplicity of infection (MOI) of 1. After 2 hours, cells were
visualized by confocal microscopy for the translocation of
phosphorylated NF-kB p65 (pNF-kB p65) into the nucleus and
the cytoplasmic and nuclear intensity of NF-kB. On day 12, the
supernatants in parallel cultures were analyzed for the level of p24.
As shown in Figure 5A, exposure of monocyte-derived macro-
phages to increasing concentrations of S-CM caused a dose-
dependent decrease in NF-kB p65 translocation into the nucleus
and a dose-dependent decrease in p24 production. However,
when S-CM at an inhibitory concentration of 250 mg protein/mL
was pre-incubated for 1 hour with anti-TGF-b antibodies at a
concentration of 100 mg/mL, S-CM inhibition of both the nuclear
translocation of NF-kB p65 and HIV-1 p24 production was
Figure 2. Intestinal S-CM down-regulates monocyte-derived
macrophage CD4 and CCR5 expression during, but not after,
differentiation. (A) Monocyte-derived macrophages were generated
by culturing monocytes for 2 days in media alone (control) or media
plus increasing concentrations of stoma-conditioned media (S-CM)
derived from normal jejunum from 2 different tissue donors and then
analyzed for CD4 and CCR5 expression by flow cytometry. Data are from
a representative experiment from 4 blood monocyte donors. (B)
Monocyte-derived macrophages were generated by culturing mono-
cytes for 4 days in media alone (control), after which S-CM (100 mg
protein/mL) was added for an additional 2 days of culture, and the cells
were analyzed for CD4 and CCR5 expression. Values are the % cells
positive for the indicated receptor in a representative experiment from
3 blood monocyte donors.
doi:10.1371/journal.ppat.1002060.g002
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antibody had no effect on S-CM inhibitory activities (Figure 5B).
Furthermore, incubation of the cells with activated, recombinant
human TGF-b (rhTGF-b at a concentration of 10 pg/mL had
little or minimal effect on NF-kB translocation or p24 production
(Figure 5C). However, rhTGF-b 50 pg/mL, which approximates
the concentration of TGF-b in S-CM 250 mg/mL, inhibited NF-
kB translocation and activity, as well as p24 production, similar to
that of S-CM 250 mg/mL (Figure 5C). Moreover, we previously
showed (flow cytometry, ELISA, immunocytochemistry and
Western blot) that LPS-exposed intestinal macrophages and S-
CM-treated blood monocytes did not phosphorylate p65, had very
Figure 3. Intestinal S-CM down-regulates HIV-1 replication in monocyte-derived macrophages. (A) MACS-sorted monocytes were
cultured for 4 days in M-CSF and the resultant monocyte-derived macrophages were cultured for an additional 2 days in the presence of S-CM at the
indicated concentrations, then inoculated with R5 virus (NA353 B27; MOI=1) for 2 hours and monitored for p24 release at 4-day intervals for 20 days
(n=4 donors, each in triplicate). (B) Monocyte-derived macrophages were cultured for 2 days with intestinal epithelial cell-conditioned media (EC-
CM), mononuclear leukocyte (MNL)-CM or S-CM derived from the same normal jejunal tissue at the indicated concentrations, inoculated with R5 virus
in triplicate as above, and analyzed for p24 release on day 12 (mean 6 SD; n=3). (C) Monocyte-derived macrophages prepared as in A were
inoculated simultaneously with R5 virus (NA353 B27; MOI=1) and S-CM, cultured for 2 hrs and then monitored for p24 release as in A (n=4 donors,
each in triplicate).
doi:10.1371/journal.ppat.1002060.g003
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and expressed markedly reduced levels of NF-kB signal proteins
(28). Expression of p50 and p65 genes also were markedly reduced
in intestinal macrophages compared to autologous blood mono-
cytes (28). These findings are consistent with minimal, if any,
transcriptionally active p50/p65 heterodimer and together
implicate stromal TGF-b-mediated down-regulation of NF-kB
activation in the inhibition of HIV-1 replication by stromal factor-
differentiated macrophages in vitro and intestinal macrophages
in vivo.
Discussion
We have shown that macrophages isolated from normal human
small intestine are highly refractory to productive HIV-1 infection
[13,14,15], supporting observations that memory CD4
+ T cells
rather than macrophages are the predominant mononuclear target
cell in the intestinal mucosa during primary HIV-1 infection
[19,20,21,22,23,24,25,26]. We also have shown that in contrast to
intestinal macrophages, vaginal macrophages are permissive to
macrophage-tropic HIV-1 [13]. Since tissue macrophages
throughout the body are derived from blood monocytes, our
findings suggest that the lamina propria of the intestinal mucosa is
a unique microenvironment capable of influencing HIV-1
permissiveness in blood monocytes recruited to the intestinal
mucosa. Consistent with this concept, we present new evidence
that products released by the intestinal extracellular matrix inhibit
up-regulation of CD4 and CCR5 during the differentiation of
blood monocytes into macrophages. However, the low level of
CD4 and CCR5 expression on intestinal macrophages is not the
exclusive cause of the cells’ non-permissiveness to HIV-1, since (1)
the very small subset (1%) of intestinal macrophages that express
CD4, a proportion of which also express CCR5, did not support
HIV-1 replication; (2) intestinal stromal products also decreased
HIV-1 replication when stromal products were added simulta-
neously to cultures of monocyte-derived macrophages, i.e., before
the induction of CD4 and CCR5 down-regulation; and (3) stromal
products inhibited single-round gene expression of VSV-G
pseudotyped virus, which enters cells independent of CD4 and
CCR5. In this connection, we previously showed that unsorted
intestinal macrophages with undetectable CD4 also do not of
support HIV-1 replication (13, 14). Having previously shown that
stromal TGF-b differentiates pro-inflammatory blood monocytes
into non-inflammatory cells with the phenotype and function of
intestinal macrophages [27] through Smad-induced IkBa expres-
sion and NF-kB signal dysregulation [28], we show here that a
critical consequence of stromal TGF-b-induced NF-kB inactiva-
tion is the profound inability of monocyte-derived macrophages to
support HIV-1 replication.
TGF-b is reported to both inhibit and stimulate HIV-1
replication, depending on the cell type, level of cell differentiation,
virus strain, timing of treatment and presence of other cytokines
[42,43,44]. In intestinal mucosa, latent TGF-b is produced by
many different types of cells, including epithelial cells, mast cells, T
Figure 4. Intestinal S-CM blocks replication of VSV-G and YU2 env pseudotyped virus. Monocytes were cultured for 4 days, inoculated
with VSV-G or YU2 env pseudotyped GFP reporter virus and cultured for an additional 2 days, after which GFP expression was analyzed by
fluorescence microscopy and flow cytometry in a representative experiment using monocyte-derived macrophages and S-CM from separate donors
(n=3).
doi:10.1371/journal.ppat.1002060.g004
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TGF-b constitutively released by these cells binds to the lamina
propria extracellular matrix binding domains and upon activation
and release regulates multiple macrophage defense and immune
functions, consistent with an elaborate and finely tuned system of
cross-talk that we have described previously [16]. Here we show
that among these functions is the down-regulation of NF-kB
activity and thus HIV-1 replication in monocyte-derived macro-
phages. These data suggest that TGF-b, at least in part, mediates
the profound non-permissiveness of intestinal macrophages to
HIV-1.
NF-kB plays a critical role in HIV-1 replication in T cells [41]
and cells of the monocyte lineage [45]. In addition to stimulating
the initiation of HIV-1 transcription [46,47,48], NF-kB also has
been implicated in promoting HIV-1 transcriptional elongation
[49,50]. Importantly, NF-kB is constitutively activated in HIV-1-
infected monocytes [51], possibly through upstream activation of
the IKK complex by HIV-1 regulatory/accessory proteins [52,53]
or HIV-1-induced (via NF-kB activation) cytokines [54]. The
activation of IKK leads to the phosphorylation and proteosomal
degradation of IkBa and IkBb, thereby releasing NF-kB for
translocation into the nucleus to bind NF-kB-binding sites in the
enhancer region of the HIV-1 long terminal repeat and host gene
promotor sites. Thus, we conclude that stromal TGF-b inactivates
NF-kB in monocyte-derived macrophages and that this inactiva-
tion likely contributes to the profound blockade in HIV-1
expression in intestinal macrophages, a highly unique population
of mononuclear phagocytes [55,56].
The HIV-1 non-permissiveness of intestinal macrophages due
to NF-kB inactivation is consistent with our recent finding that
stromal TGF-b dysregulation of NF-kB signaling causes inflam-
mation anergy in intestinal macrophages [28]. Importantly, long-
term culture of intestinal macrophages in the absence of stromal
factors does not restore inflammatory capability [27,28] and, as
reported here, did not promote the emergence of HIV-1
permissiveness, indicating prolonged, if not permanent, down-
regulation of these functions in intestinal macrophages. Also,
exposure of intestinal macrophages to pro-inflammatory stimuli,
including lipopolysaccharide (LPS), interferon-c (IFN-c) and
tumor necrosis factor-a (TNF-a), does not induce inflammatory
function [27,28] and did not restore replication competence.
These findings suggest that in primary HIV-1 infection, resident
macrophages in healthy intestinal mucosa are incapable of de novo
HIV-1 replication.
In contrast to primary HIV-1 infection, in late stage disease
HIV-1-infected blood monocytes may recruit to intestinal mucosa
that is either inflamed or infected with opportunistic pathogens. In
such a microenvironment, dysregulated homeostasis permits viral
replication to continue after the monocytes take up residence in
the lamina propria, as we have reported for esophageal
macrophages in patients with AIDS and opportunistic mucosal
infections [57]. We also have reported that cytomegalovirus blocks
stromal inhibition of HIV-1 infection of macrophages and that this
inhibition is mediated, at least in part, by cytomegalovirus-induced
monocyte production of TNF-a, which acts in trans to enhance
HIV-1 replication [58]. However, the very low levels of TNF-a
(,2.9 pg/mL) in S-CM generated from normal mucosa and
inflamed Crohn’s mucosa [59] suggest that TNF-a is not involved
in stromal down-regulation of intestinal macrophage permissive-
ness to HIV-1.
In the present study, we investigated HIV-1 permissiveness in
intestinal macrophages using highly macrophage-tropic R5
viruses, including NA420 B33, NA20 B59 and NA353 B27
[39,59], in order to maximize the possibility of infecting intestinal
macrophages. Interestingly, infectious molecular clones of trans-
mitted founder viruses derived from acutely infected persons are
R5-tropic but fail to replicate efficiently in monocyte-derived
macrophages [60,61]. Although we have not yet examined the
ability of these molecular clones to infect intestinal macrophages,
such infection seems unlikely, since intestinal macrophages do not
activate NF-kB, a requirement for HIV-1 gene transcription
during macrophage differentiation [45].
The findings presented here do not exclude the possibility that
HIV-1 restriction factors other than TGF-b are present in the
stroma and thus S-CM. S-CM was used in a range of 10-1000 mg
protein/mL, corresponding to TGF-b in the range of 1–150 pg/
mL. Although rhTGF-b at a concentration of 10 pg/L had little or
minimal effect on NF-kB translocation or p24 production
(Figure 5C), rhTGF-b 50 mg/mL, which approximates the
concentration of TGF-b in S-CM 250 mg/mL, inhibited NF-kB
translocation and viral replication (p24 production), similar to that
of S-CM 250 mg/mL. Apolipoprotein B mRNA-editing enzyme
catalytic polypeptide-like 3G (APOBEC3G), which causes dC-to-
dU mutations in viral DNA, is reported to be induced by LPS in
dendritic cells and by IFN-a in monocyte-derived macrophages
[62,63]; however, we have been unable to detect APOBEC3G in
resting or IFN-a-treated intestinal macrophages. Also, higher
levels of anti-HIV-1 miRNAs have been reported to inhibit HIV-1
in monocytes [64,65], but the role of miRNA as a restriction factor
in monocytes is controversial [66,67]. A cellular restriction factor
that is neutralized by primate lentiviral Vpx protein was recently
detected in quiescent monocytes, but its reduction as the cells
differentiate into macrophages makes it an unlikely restriction
factor in terminally differentiated intestinal macrophages [68].
Other potential restriction factors, including p21 [69,70] and
interferon-induced C/EBPb [71,72], have been proposed but have
not yet been investigated in mucosal macrophages.
A confounding issue regarding post-entry restrictions in
intestinal macrophages is that such restrictions would be unique
to macrophages residing in the intestinal mucosa, since macro-
phages in the vaginal mucosa are highly replication competent
[13]. Although the extracellular matrix could release products that
induce yet-to-be-identified anti-viral restrictions, the findings
presented here implicate stromal TGF-b-induced NF-kB inacti-
vation as contributing to the non-permissiveness of macrophages
in the human small intestine. These findings help explain the
Figure 5. Down-regulation of NF-kB by S-CM correlates with down-regulation in the cells’ ability to support HIV-1 replication. (A)
Monocytes were cultured in media plus M-CSF and then inoculated in triplicate with R5 HIV-1 (NA353 B27; MOI=1) plus S-CM at the indicated
concentration for 2 hours. Cells were evaluated for NF-kB p65 translocation by confocal microscopy and NF-kB intensity by IPLab image analysis
software after 2 hours and for viral replication by p24 ELISA on day 12 (n=3 donors). Histograms are representative of a single experiment and show
distribution of NF-kB (green line) in relation to the nucleus (blue line). The p24 value of each treatment was normalized to the media control group
with the replication level of media control group defined as 100%. Data shown are the means of relative p24 levels from independent experiments
with 3 donors. (B) Anti-TGF-b antibodies reverse the inactivation of NF-kB and S-CM-mediated down-regulation of HIV-1 replication. Experiments
were performed as in A except the S-CM (250 mg protein/mL) was pre-incubated for 1 hour with anti-TGF-b antibodies at the indicated concentration
(n=3 donors). (C) Recombinant human TGF-b reduces NF-kB translocation and R5 virus replication. Experiments were performed as in A, except the
S-CM was replaced with rhTGF-b at 10 or 50 pg/mL (n=4 donors).
doi:10.1371/journal.ppat.1002060.g005
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phages, in sharp contrast to the highly productive infection in
intestinal T cells, in primary HIV-1 infection. The ability of
intestinal CD4
+ T cells to support robust HIV-1 replication is well
established in our in vitro [13] and in vivo studies [9,10,11,12,
13,14,15,16,17,18,19,20,21,22,23,24,25,26]. Furthermore, TGF-b
does not inhibit HIV-1 expression in a chronically infected T cell
line or in primary T cell blasts infected in vitro with HIV-1 [42]. The
discordance between intestinal T cell and macrophage support
for HIV-1 replication in the presence of down-regulatory stromal
TGF-b is currently under investigation in our laboratory. Thus, the
unique dysregulation in NF-kB signaling induced in monocytes by
extracellular matrix products, especially TGF-b, when the cells take
up residence in the intestinal mucosa, offers a mechanism by which
the host down-regulates mucosal macrophages for harmful pro-
inflammatory responses and permissiveness to viruses in which
transcriptionis NF-kB-dependent. Harnessing thisnaturalanti-viral
defense mechanism may provide a novel strategy to exploit for the
prevention of infection in HIV-1 permissive cells.
Materials and Methods
Ethics statement
All tissue and cell protocols were approved by the Institutional
Review Board of the University of Alabama at Birmingham.
Written informed consent was provided by study participants.
Intestinal macrophages and blood monocytes
Macrophages were isolated from segments of intestinal mucosa
of otherwise healthy subjects undergoing elective gastric bypass by
enzyme digestion and purified by counterflow centrifugal
elutriation, as previously described [73,74,75]. Circulating blood
monocytes from the same donors were purified by gradient
sedimentation followed by magnetic anti-PE bead isolation of anti-
CD14-PE-treated cells per the manufacture’s manual (Miltenyi
Biotec). All studies were performed using fresh cells. Macrophages
and monocytes were routinely .98% pure and 98% viable by
propidium iodide staining. CD4
+ monocytes and intestinal
macrophages were isolated by magnetic CD4
+ microbead
separation.
HIV-1 molecular clones and viruses
Macrophage-tropic viruses were prepared as previously de-
scribed [13,76,77]. Briefly, replication competent clones of highly
macrophage-tropic R5 viruses, including NA420 B33, NA20 B59
and NA353 B27 [39], were transfected into 293T cells by Fugene
6 (Roche), according to the manufacture’s protocol. After
60 hours, the supernatants were harvested, clarified by low speed
centrifugation (1,000 g, 10 minutes), filtered (0.45 mm filter),
titrated using JC53BL cells [78], aliquoted and stored at 280uC.
YU2 envelope (Env) or vesicular stomatitis virus glycoprotein
(VSV-G) HIV-1 pseudovirions that express GFP upon infection
were kindly provided by D. Levy, NYU and constructed as follows.
Briefly, the env gene was deleted and the gfp gene was inserted
between the env and nef genes of the pNL4-3 clone. An internal
ribosome entry site (IRES) element was inserted between the gfp
and nef genes to rescue nef gene expression [79]. To generate the
YU2 Env or VSV-G GFP reporter pseudovirions, the clone was
co-transfected with the YU2 Env or VSV-G expression plasmid
into 293T cells and harvested, as described above.
Conditioned media
Using our previously described protocols [40,73,74], epithelium
and lamina propria mononuclear cells (MNLs) were removed by
enzyme digestion from segments of normal human jejunum from
otherwise healthy subjects undergoing elective gastric bypass, and
purified by elutriation. The epithelial cells (EC) (10610
6/mL),
lamina propria MNLs (10610
6/mL), and cell-depleted lamina
propria stroma (1 g wet wt stromal tissue/mL), respectively, were
cultured in RPMI for 24 hours without serum, and the EC-
conditioned media (EC-CM), MNL-CM and stroma-CM (S-CM)
were harvested, sterile-filtered (0.2 mm Syringe Filter; Corning
Inc.) and frozen at 270uC, as previously described [27,28]. Cell
depletion from lamina propria stroma was confirmed by
immunohistochemistry [73]; intestinal macrophages expressed
barely detectable CD14 [13]. Conditioned media did not alter
monocyte-derived macrophage viability during incubation for as
long as 4 days as assessed by flow cytometric analysis of propidium
iodide uptake. S-CMs were normalized to 500 mg/mL RPMI.
Endotoxin and protein content were determined by ELISA
(endotoxin ELISA: Cambrex Bio Science; protein ELISA: Pierce
Protein Research Products/Thermo Scientific). Only endotoxin-
free EC-CM, MNL-CM and S-CM were used in the experiments.
Flow cytometry
Intestinal macrophages and monocytes were incubated with
optimal concentrations of PE-, APC-, or FITC-conjugated
antibodies to HLA-DR, CD13, CD4, CCR5 (BD Pharmingen),
or control mAbs of the same isotype at 4uC for 20 minutes, washed
with PBS, fixed with 1% paraformaldehyde and analyzed by flow
cytometry. Data were analyzed with FlowJo software (Tree Star,
Inc.). To examine the effect of S-CM on CD4 and CCR5
expression in monocyte-derived macrophages, blood monocytes
were cultured in 48-well plates at 5610
5 cells/well in RPMI plus
macrophage colony-stimulating factor (M-CSF) serum and S-CM
at final concentrations of 0, 10, 100 and 500 mg/mL for up to 3
days and analyzed for CD4 and CCR5. Student’s t-test was used
to determine the statistical significance of the difference of
expression levels of these receptors between intestinal macrophag-
es and autologous blood.
HIV-1 infection of intestinal macrophages and
monocyte-derived macrophages
Sorted intestinal macrophages and monocytes from 2 donors
were cultured in triplicate in 96-well plates at 2610
5 cells/well in
RPMI plus M-CSF and serum for 4 days. Cultures then were
inoculated with NA20 B59, NA353 B27 or NA420 B33 at an
MOI=1, cultured for the indicated duration with 100 mLo f
supernatant, harvested every 4 days and stored at 270uC until
assayed for p24 by ELISA (PerkinElmer).
To examine the effect of S-CM on macrophage permissiveness
to HIV-1, MACS-sorted monocytes were cultured for 4 days in
RPMI plus M-CSF to generate monocyte-derived macrophages,
after which S-CM was added at final concentrations of 10, 100
and 500 mg protein/mL. Control cultures of monocyte-derived
macrophages were incubated in media alone. Two days later,
culture supernatants were removed, and triplicate cultures were
inoculated with NA353 B27 (MOI=1) for 2 hours, cultured for 20
days, and the kinetics of p24 production was determined as above.
Parallel triplicate cultures of monocyte-derived macrophages were
inoculated simultaneously with NA353 B27 (MOI=1) plus S-CM
(final concentrations of 0, 10, 100 and 500 mg protein/mL) for
2 hours, and viral replication was monitored as above.
Cultures of monocyte-derived macrophages prepared as above
were inoculated with NA353 B27 (MOI=1) plus S-CM or with S-
CM only. Cells treated with S-CM only were harvested after
2 hours, cytospun onto glass slides and stained for NF-kB p65.
Cells infected with virus were cultured, and supernatants were
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monocyte-derived macrophages were inoculated for 2 hours in
triplicate with NA353 B27 (MOI=1) plus S-CM 250 mg protein/
mL pre-treated with 0, 25 or 100 mg/mL of anti- TGF-b for
1 hour at 37uC. Analysis of viral replication and NF-kB p65
staining were performed as above.
A final aliquot of monocyte-derived macrophages prepared as
above was cultured for 6 days, inoculated in triplicate with NA353
B27 (MOI=1) plus rhTGF-b (R&D Systems) or rhTGF-b only at
final concentrations of 0, 10, or 50 pg/mL for 2 hours. Evaluation
of NF-kB p65 intensity and viral replication were performed as
above.
Immunofluorescence staining for NF-kB p65
Cells cytospun onto glass slides were fixed and permeabilized
with Cytofix/Cytoperm (BD Biosciences) for 20 minutes. After
washing with PBS, cells were blocked with casein protein (DAKO)
for 1 hour and incubated with rabbit anti-NF-kB p65 or isotype
control antibodies (Santa Cruz Biotechnology) for 90 minutes,
washed with PBS, incubated with donkey anti-rabbit IgG-FITC
(Jackson ImmunoResearch Laboratories) for 30 minutes, washed
with PBS and counterstained with DAPI nuclear stain. Cells were
visualized by confocal microscopy, and the cytoplasmic and
nuclear fluorescence intensity of NF-kB was converted to
histograms using IPLab image analysis software version 3.6 (BD
Biosciences Bioimaging).
For comparison of the effects of treatment on NK-kB activity,
NF-kB intensity was normalized to the blue signal in the nucleus.
Five images were analyzed per sample and mean intensities were
generated. For comparison of the effects of treatment on HIV-1
replication, p24 value of each treatment was normalized to the
media control group with the replication level of the media control
group defined as 100%. Statistical significance was determined by
Student’s t-test.
Statistical analysis
Data is expressed as mean 6 SD or 6 SEM, and statistical
significance between groups was determined using Student’s t-test.
P values #0.05 were considered significant.
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